ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC

PrivateCIK: 1917529
Location

CAMBRIDGE, MA

πŸ“‹ What this filing means

ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $906.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

17
Positions
$906.2K
Total AUM (reported)
78.18M
Total Shares

Allocation by class

TOTAL AUM$906.2K17 positions
COMMON STOCK$906.2K100.0%

Portfolio Concentration

Top 357.4%4–1039.1%11–253.5%TOP 1096.5%0%100%
Top 3$520.2K57.4%
4–10$354.5K39.1%
11–25$31.4K3.5%

Top 3 weight

57.4%

Top 10 weight

96.5%

Voting Authority Distribution

Total shares with voting rights: 78.18M

Sole

Full voting authority

78.18M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole17
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings17
Rows:

Third Harmonic Bio, Inc.

SOLE
Common Stock
Shares10.91M
TypeSH
Market value$206.9K
22.83%
Sole
10.91M
Shared
0.00
None
0.00

Day One Biopharmaceuticals, Inc.

SOLE
Common Stock
Shares8.17M
TypeSH
Market value$163.6K
18.06%
Sole
8.17M
Shared
0.00
None
0.00

Kymera Therapeutics, Inc.

SOLE
Common Stock
Shares6.88M
TypeSH
Market value$149.7K
16.52%
Sole
6.88M
Shared
0.00
None
0.00

Dyne Therapeutics, Inc.

SOLE
Common Stock
Shares8.93M
TypeSH
Market value$113.5K
12.52%
Sole
8.93M
Shared
0.00
None
0.00

Replimune Group, Inc.

SOLE
Common Stock
Shares3.11M
TypeSH
Market value$53.7K
5.92%
Sole
3.11M
Shared
0.00
None
0.00

Vigil Neuroscience, Inc.

SOLE
Common Stock
Shares5.84M
TypeSH
Market value$53.1K
5.86%
Sole
5.84M
Shared
0.00
None
0.00

Generation Bio, Co.

SOLE
Common Stock
Shares8.28M
TypeSH
Market value$44.0K
4.85%
Sole
8.28M
Shared
0.00
None
0.00

Aerovate Therapeutics, Inc.

SOLE
Common Stock
Shares2.33M
TypeSH
Market value$38.6K
4.26%
Sole
2.33M
Shared
0.00
None
0.00

Akero Therapeutics, Inc.

SOLE
Common Stock
Shares994.25K
TypeSH
Market value$33.9K
3.74%
Sole
994.25K
Shared
0.00
None
0.00

Ikena Oncology, Inc.

SOLE
Common Stock
Shares5.02M
TypeSH
Market value$17.8K
1.97%
Sole
5.02M
Shared
0.00
None
0.00

Gemini Therapeutics, Inc.

SOLE
Common Stock
Shares5.25M
TypeSH
Market value$8.6K
0.95%
Sole
5.25M
Shared
0.00
None
0.00

Xilio Therapeutics, Inc.

SOLE
Common Stock
Shares2.76M
TypeSH
Market value$8.0K
0.89%
Sole
2.76M
Shared
0.00
None
0.00

Magenta Therapeutics, Inc.

SOLE
Common Stock
Shares3.48M
TypeSH
Market value$4.9K
0.54%
Sole
3.48M
Shared
0.00
None
0.00

F-star Therapeutics, Inc.

SOLE
Common Stock
Shares599.52K
TypeSH
Market value$3.1K
0.34%
Sole
599.52K
Shared
0.00
None
0.00

AvroBio, Inc.

SOLE
Common Stock
Shares4.52M
TypeSH
Market value$2.9K
0.32%
Sole
4.52M
Shared
0.00
None
0.00

Spero Therapeutics, Inc.

SOLE
Common Stock
Shares1.03M
TypeSH
Market value$2.1K
0.23%
Sole
1.03M
Shared
0.00
None
0.00

Viridian Therapeutics, Inc.

SOLE
Common Stock
Shares90.07K
TypeSH
Market value$1.8K
0.20%
Sole
90.07K
Shared
0.00
None
0.00
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 13F Holdings β€” 17 Positions | Finecho